首页工具

登录

搜索结果

Search Results for " pharmacokinetic "

152

抑制剂 & 化合物

3

天然产物

如果没找到您满意的产品或者您对产品有其他要求，可以联系我们专业顾问为您提供针对性的合理建议。 QQ咨询网站留言咨询

Cat. No.	Product Name	Target	Signaling Pathways
T1803	GNF-5 GNF 5	SARS-CoV; Bcr-Abl	Angiogenesis; Cytoskeletal Signaling; Microbiology/Virology; Tyrosine Kinase/Adaptors
	GNF-5是 Bcr-Abl 的特异性非 ATP 竞争性抑制剂，IC50为0.22uM。它是 GNF-2 的类似物，具有改进的药代动力学特性。
T13099	TC ASK 10	ASK; MAPK	Apoptosis; MAPK
	TC ASK 10 是选择性的，口服有效的细胞凋亡信号调节激酶 1 抑制剂，IC50为 14 nM。它对其他代表性激酶的抑制活性低于 50％，除 ASK2之外 (IC50为 0.51 μM)。
T4989	Fosfomycin Tromethamine	Antibacterial; Antibiotic	Microbiology/Virology
	Fosfomycin tromethamine 是一种能透过血脑屏障的广谱抗生素，不可逆地抑制细胞壁合成的早期阶段。它对多种细菌具有杀菌活性，包括耐多药、广泛耐药和耐全药细菌。
T2397	Topiroxostat 托匹司他,FYX-051	P450; ROS; Xanthine Oxidase	Immunology/Inflammation; Metabolism
	Topiroxostat (FYX-051) 是一种有效的口服黄嘌呤氧化还原酶 (XOR) 抑制剂，IC50=5.3 nM，Ki=5.7 nM。它还表现出弱的CYP3A4抑制活性 (18.6%)。它有用于高尿酸血症的研究潜力。
T3131	Fosfomycin calcium Phosphomycin calcium salt,Fosmicin,磷霉素钙	Antibacterial; Antibiotic	Microbiology/Virology
	Fosfomycin calcium (Phosphomycin calcium salt) 是一种能透过血脑屏障的广谱抗生素，不可逆地抑制细胞壁合成的早期阶段。它对多种细菌具有杀菌活性，包括耐多药、广泛耐药和耐全药细菌。
T9643	ZN-c3	Wee1	Cell Cycle/Checkpoint
	ZN-c3 是一种有效的选择性 Wee1 抑制剂，具有平衡的效力、ADME 和药代动力学特性。
T34705	SR4554 SR 4554
	SR4554 is a fluorine-containing 2-nitroimidazole, designed as a hypoxia marker detectable with 19F magnetic resonance spectroscopy (MRS). SR-4554 has plasma pharmacokinetic and toxicity profiles suitable for use as a hypoxia probe. It can be detected in t
T69757	PDDC inhibitor
	PDDC is the first nSMase2 inhibitor that possesses both favorable pharmacodynamics and pharmacokinetic (PK) parameters, including substantial oral bioavailability, brain penetration, and significant inhibition of exosome release from the brain in vivo.
T14338	Atabecestat JNJ-54861911	BACE	Neuroscience
	Atabecestat (JNJ-54861911) is a potent brain-penetrant and orally active β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitor, achieves robust and high CSF Aβ reduction and it is tolerated and displays a sustained pharmacokinetic (PK) and
T19858	Brodimoprim	DHFR; Antibacterial	Cell Cycle/Checkpoint; DNA Damage/DNA Repair; Metabolism; Microbiology/Virology
	Brodimoprim 是甲氧苄啶的一种类似物，是口服有效的二氢叶酸还原酶抑制剂，对广谱革兰氏阴性和革兰氏阳性细菌具有高度的抑制作用。
T22338	2,6-Dichloro-N-(2-(cyclopropanecarboxamido)pyridin-4-yl)benzamide GDC046	Others; JAK	Angiogenesis; Chromatin/Epigenetic; JAK/STAT signaling; Others; Stem Cells
	2,6-Dichloro-N-(2-(cyclopropanecarboxamido)pyridin-4-yl)benzamide (GDC046) 是一种具有口服活性的选择性TYK2抑制剂，对 TYK2、JAK1、JAK2 和 JAK3 的Ki 分别为 4.8、0.7、0.7 和 0.4 nM。
T26252	PI3Kδ-IN-3 TC KHNS 11	PI3K	PI3K/Akt/mTOR signaling
	PI3Kδ-IN-3 (TC KHNS 11) 是一种 PI3Kδ 抑制剂，IC50 值为 9 nM。PI3Kδ-IN-3 具有良好的药代动力学特性且对 B 细胞功能有抑制作用。
T37082	HS271	IRAK	Immunology/Inflammation; NF-κB
	HS271 是一个选择性的、口服有效的 IRAK4 抑制剂 (IC50= 7.2 μM)。HS271 表现出优越的体外酶活性和细胞活性以及药代动力学特征。
T26969	CCT365623 CCT-365623,CCT 365623	Monoamine Oxidase	Neuroscience
	CCT365623 是一种口服生物可利用的赖氨酰氧化酶抑制剂，具有良好的抗 LOX 效力、选择性、药代动力学特性以及抗转移功效。
T16679	Belzutifan PT2977,MK-6482	HIF	Angiogenesis; Chromatin/Epigenetic
	Belzutifan (MK-6482) 是具有口服活性的 HIF-2α选择性抑制剂，IC50为 9 nM。Belzutifan 具有提高的效力和改善的药代动力学特征。Belzutifan (MK-6482) 可以抑制透明细胞肾细胞癌。
T26863	BMS-929075 BMS 929075,BMS929075	HCV Protease	Microbiology/Virology; Proteases/Proteasome
	BMS-929075是一种具有口服活性 HCV NS5B 复制酶 (HCV NS5B replicase) 手掌位点变构抑制剂，具有有效性、较高的口服生物利用度和药代动力学参数。BMS-929075 显示出细胞毒性。
T6100	Torin 2	Apoptosis; ATM/ATR; DNA-PK; mTOR; Autophagy	Apoptosis; Autophagy; DNA Damage/DNA Repair; PI3K/Akt/mTOR signaling
	Torin 2 是一种特异性 mTOR 抑制剂，IC50值为0.25 nM，并改善了药代动力学特性。它抑制 ATM/ATR/DNA-PK 的 EC50 分别为 28 nM/35 nM/118 nM。
T9642	ZW4864 free base	Wnt/beta-catenin	Cytoskeletal Signaling; Stem Cells
	ZW4864 free base 是口服有效的，选择性的 β catenin/ B-Cell lymphoma 9 蛋白-蛋白相互作用 (β catenin/BCL9 PPI) 抑制剂 (Ki= 0.76 μM, IC50= 0.87 μM)。
T64355	TDI-10229	cAMP	GPCR/G Protein
	TDI-10229 是一种口服有效的可溶性腺苷酸环化酶 (sAC, ADCY10) 抑制剂 (IC50 值为 195 nM)。TDI-10229 在生化和细胞分析中都显示出对 sAC 的纳摩尔级抑制，并表现出足以保证其用作体内工具化合物的小鼠药代动力学特性。
T63208	Aβ-IN-1	Gamma-secretase	Neuroscience; Proteases/Proteasome; Stem Cells
	Aβ-IN-1 是一种新型有效且具有口服活性的 γ 分泌酶调节剂 (GSM)。 Aβ-IN-1 在不抑制 CYP3A4 的情况下，在培养细胞中有效降低 Aβ42 水平，IC50值为 0.091 μM。Aβ-IN-1 显示出良好的药代动力学特征。
T73593	PDS-0330	Others	Others
	PDS-0330是一种 claudin-1小分子抑制剂抑制。PDS-0330抑制 claudin-1依赖性 CRC 进展，以微摩尔亲和力直接和特异性地与claudin-1结合。PDS-0330通过抑制与转移性癌基因Src 的关联，表现出具有良好药代动力学特性的抗肿瘤和化学增敏活性。PDS-0330干扰claudin-1 / Src 关联以抑制CRC 进展和转移。
T14835	BTRX-335140 CYM-53093	Opioid Receptor	Endocrinology/Hormones; GPCR/G Protein; Neuroscience
	BTRX-335140 (CYM-53093) 是一种有效的选择性口服活性 κ 阿片受体 (KOR) 拮抗剂，对 κOR、μOR 和 δOR 具有拮抗活性，IC50 值分别为 0.8、110 和 6500 nM。它可以很好地分布到 CNS 中，在大鼠中具有良好的体外吸收、分布、代谢、排泄和毒性以及体内药代动力学特征。
T21537L	TMC647055 Choline Hydroxide Salt TMC647055 Choline Hydroxide Salt (1204416-97-6 free base)	HCV Protease	Microbiology/Virology; Proteases/Proteasome
	TMC647055 Choline Hydroxide Salt 是一种新型有效的 HCV NS5B 聚合酶非核苷抑制剂，可用于治疗 HCV 感染。它具有纳摩尔级细胞效力（EC(50) 为 82 nM），相关细胞毒性较小（CC(50)>20 μM），在大鼠和狗中具有良好的药代动力学特征。 TMC647055 显示出有体外生化、动力学和病毒学特征的前景。
T30303	BAY8040 BAY 8040,BAY-8040
	BAY8040 is a potent selective human neutrophilic elastase inhibitor with excellent potency and selectivity with promising pharmacokinetic characteristics.
T33442	MK-8718 MK 8718
	MK-8718 is an HIV protease inhibitor with a selective orally bioavailable inhibitor with good pharmacokinetic characteristics.
T32006	GSK-2262167 sodium GSK-2262167,GSK2262167,GSK 2262167
	GSK-2262167 is a potent S1P1 agonist, as effective as fingolimod in collagen-induced arthritis models, and shows good preclinical pharmacokinetic properties.
T27982	MBRI-001 MBRI 001,MBRI001. BPI-2358-d,plinabulin-d,NPI-2358-d
	MBRI-001 is a deuterium-substituted plinabulin derivative and a potent anti-cancer agent with better pharmacokinetic characteristics tand lower toxicity.
T70033	NCATS-SM1440
	NCATS-SM1440 is a Lactate Dehydrogenase Inhibitor with Optimized Cell Activity and Pharmacokinetic Properties.
T12795	(S)-Ceralasertib (S)-AZD6738	Others	Others
	(S)-Ceralasertib is a potent and selective inhibitor of sulfoximine morpholinopyrimidine ATR with excellent preclinical physicochemical and pharmacokinetic (PK) characteristics. .
T35852	FAPI-34
	FAPI-34, a fibroblast-activating protein (FAP) inhibitor, boasts advantageous pharmacokinetic and biochemical attributes.
T40238	Tenofovir-C3-O-C12-trimethylsilylacetylene ammonium Tenofovir-C3-O-C12-trimethylsilylacetylene ammonium
	Tenofovir-C3-O-C12-trimethylsilylacetylene (ammonium) displays a prolonged half-life (t1/2) compared to tenofovir in human liver microsomes. Moreover, it demonstrates potent in vitro anti-HIV activity and improves in vivo pharmacokinetic properties.
T26309	Umirolimus Biolimus-A9,TRM-986,TRM 986,TRM986,Biolimus A9
	Umirolimus is a sirolimus derivative from a biodegradable polylactic acid polymer. It has enhanced anti-inflammatory and antiproliferative activity with an improved pharmacokinetic profile.
T68826	A33903
	A33903 is a 1,4-benzodiazepine analog that is being studied as a potential inhibitor of respiratory syncytial virus. This molecule was moderately active and demonstrated good pharmacokinetic properties.
T40280	JH-XVI-178
	JH-XVI-178 is a highly potent and selective CDK8/19 inhibitor with favorable pharmacokinetic attributes, including low clearance and moderate oral bioavailability.
T38135	3,4-Dehydro Cilostazol
	3,4-Dehydro Cilostazol (OPC-13015) is an active metabolite of Cilostazol. 3,4-Dehydro Cilostazol is used for pharmacokinetic study[1]. [1]. T R S Satheeshmanikandan, et al. Liquid Chromatography - Tandem Mass Spectrometry for the Simultaneous Quantitation of Glipizide, Cilostazol and Its Active Metabolite 3, 4-dehydro-cilostazol in Rat Plasma: Application for a Pharmacokinetic Study. Arzneimittelforschung. 2012 Sep;62(9):425-32.
T11377	GDC-0276	Others	Others
	GDC-0276, a potent, selective, reversible, and orally active NaV1.7 inhibitor with an IC50 value of 0.4 nM, offers potential for pain treatment while overcoming limitations associated with current pain medications, including addiction and off-target side effects. It is well tolerated and demonstrates a favorable pharmacokinetic profile.
T24366	L 870810 L-870,810,L870810,L 870,810,L870,810,L-870810
	L 870810 is a small-molecule inhibitor of HIV-1 integrase with potent antiviral activity in cell culture and good pharmacokinetic properties.
T40092	MNK/PIM-IN-1
	MNK/PIM-IN-1 is a novel dual inhibitor targeting both MNK and PIM pathways, characterized by its favorable pharmacokinetic profile.
T23807	BMS-955176 TFA BMS 955176,GSK-3532795,BMS955176,BMS-955176,GSK3532795
	GSK3532795 is an orally active inhibitor of HIV-1 maturation. GSK3532795 combines broad coverage of polymorphic viruses (EC50: 15 nM toward a panel of common polymorphisms representative of 96.5% HIV-1 subtype B virus) with a favorable pharmacokinetic pro
T25558	JNJ-55511118 JNJ 55511118
	JNJ-55511118 is a selective negative modulator of AMPA receptors containing TARP-γ8 (Ki: 26 nM). It had excellent pharmacokinetic properties. JNJ-55511118 exhibited a dose-dependent inhibition of neurotransmission within the hippocampus and a strong antic
T11548	HCV-IN-7	Others	Others
	HCV-IN-7 is an orally active and potent pan-genotypic HCV NS5A inhibitor (IC50s: 3-47 pM). It shows a superior pan-genotypic profile and a good pharmacokinetic profile coupled with a favorable liver uptake.
T68356	AM-3189
	AM-3189 is a potent and selective GPR40 Agonist with minimal CNS penetration, superior pharmacokinetic properties and in vivo efficacy comparable to AMG 837. AM-3189 maintains the in vivo efficacy of AMG 837 while displaying a superior pharmacokinetic profile and minimal CNS exposure. Similar to AMG 837, while highly potent on GPR40, AM-3189 was highly selective over the closely related GPCRs, GPR41 and GPR43. 13kdemonstrated low clearance, moderate volume of distribution, and good oral bioavai...
T11972	Mcl-1 inhibitor 3	BCL	Apoptosis
	Mcl-1 inhibitor 3 shows good pharmacokinetic properties and excellent in vivo efficacy without toxicity.Mcl-1 inhibitor 3 is a highly potent and orally activate macrocyclic Mcl-1 inhibitor (Ki= 0.061 nM; IC50=19 nM in an OPM-2 cell viability assay).
T40239	Tenofovir-C3-O-C15-CF3 ammonium Tenofovir-C3-O-C15-CF3 ammonium
	Tenofovir-C3-O-C15-CF3 (ammonium) demonstrates prolonged half-life values compared to tenofovir in human liver microsomes. It exhibits potent anti-HIV activity in vitro and enhances pharmacokinetic properties in vivo.
T11548L	HCV-IN-7 hydrochloride	Others	Others
	HCV-IN-7 hydrochloride is an orally active and potent pan-genotypic HCV NS5A inhibitor (IC50s: 3-47 pM). It shows a superior pan-genotypic profile and a good pharmacokinetic profile coupled with a favorable liver uptake.
T70754	NMS-P953
	NMS-P953 is a JAK2 inhibitor, displaying significant tumor growth inhibition in SET-2 xenograft tumor model. NMS-P953 has a mechanism of action confirmed in vivo by typical modulation of known biomarkers, and with a favorable pharmacokinetic and safety profile.
T69761	ZL0516
	ZL0516 is a is a chromone derivatives used as orally bioavailable BRD4-selective inhibitor. This BRD4 BD1 inhibitor has demonstrated impressive in vivo efficacy and overall promising pharmacokinetic properties, indicating its therapeutic potential for the treatment of inflammatory diseases.
T69762	ZL0513
	ZL0513 is a chromone derivatives used as orally bioavailable BRD4-selective inhibitor. This BRD4 BD1 inhibitor has demonstrated impressive in vivo efficacy and overall promising pharmacokinetic properties, indicating its therapeutic potential for the treatment of inflammatory diseases.
T69776	BAY-707 acetate
	BAY-707 is a substrate-competitive, highly potent and selective inhibitor of MTH1. Despite superior cellular target engagement and pharmacokinetic properties, inhibition of MTH1 with BAY-707 resulted in a clear lack of in vitro or in vivo anticancer efficacy either in mono- or in combination therapies.
T37290	Resolvin D3 methyl ester
	Resolvin D3 methyl ester is a methyl ester version of the free acid that may act as a lipophilic prodrug form that will alter its distribution and pharmacokinetic properties. The methyl ester moiety is susceptible to cleavage by intracellular esterases, leaving the free acid.

化合物

Cat.No: T1803

Synonym: GNF 5

Target: SARS-CoV, Bcr-Abl

Cat.No: T13099

Target: ASK, MAPK

Fosfomycin Tromethamine

Cat.No: T4989

Target: Antibacterial, Antibiotic

Cat.No: T2397

Synonym: 托匹司他,FYX-051

Target: P450, ROS, Xanthine Oxidase

Fosfomycin calcium

Cat.No: T3131

Synonym: Phosphomycin calcium salt,Fosmicin,磷霉素钙

Target: Antibacterial, Antibiotic

Cat.No: T9643

Target: Wee1

Cat.No: T34705

Synonym: SR 4554

Cat.No: T69757

Cat.No: T14338

Synonym: JNJ-54861911

Target: BACE

Cat.No: T19858

Target: DHFR, Antibacterial

2,6-Dichloro-N-(2-(cyclopropanecarboxamido)pyridin-4-yl)benzamide

Cat.No: T22338

Synonym: GDC046

Target: Others, JAK

Cat.No: T26252

Synonym: TC KHNS 11

Target: PI3K

Cat.No: T37082

Target: IRAK

Cat.No: T26969

Synonym: CCT-365623,CCT 365623

Target: Monoamine Oxidase

Cat.No: T16679

Synonym: PT2977,MK-6482

Target: HIF

Cat.No: T26863

Synonym: BMS 929075,BMS929075

Target: HCV Protease

Cat.No: T6100

Target: Apoptosis, ATM/ATR, DNA-PK, mTOR, Autophagy

ZW4864 free base

Cat.No: T9642

Target: Wnt/beta-catenin

Cat.No: T64355

Target: cAMP

Cat.No: T63208

Target: Gamma-secretase

Cat.No: T73593

Target: Others

Cat.No: T14835

Synonym: CYM-53093

Target: Opioid Receptor

TMC647055 Choline Hydroxide Salt

Cat.No: T21537L

Synonym: TMC647055 Choline Hydroxide Salt (1204416-97-6 free base)

Target: HCV Protease

Cat.No: T30303

Synonym: BAY 8040,BAY-8040

Cat.No: T33442

Synonym: MK 8718

GSK-2262167 sodium

Cat.No: T32006

Synonym: GSK-2262167,GSK2262167,GSK 2262167

Cat.No: T27982

Synonym: MBRI 001,MBRI001. BPI-2358-d,plinabulin-d,NPI-2358-d

Cat.No: T70033

(S)-Ceralasertib

Cat.No: T12795

Synonym: (S)-AZD6738

Target: Others

Cat.No: T35852

Tenofovir-C3-O-C12-trimethylsilylacetylene ammonium

Cat.No: T40238

Synonym: Tenofovir-C3-O-C12-trimethylsilylacetylene ammonium

Cat.No: T26309

Synonym: Biolimus-A9,TRM-986,TRM 986,TRM986,Biolimus A9

Cat.No: T68826

Cat.No: T40280

3,4-Dehydro Cilostazol

Cat.No: T38135

Cat.No: T11377

Target: Others

Cat.No: T24366

Synonym: L-870,810,L870810,L 870,810,L870,810,L-870810

Cat.No: T40092

Cat.No: T23807

Synonym: BMS 955176,GSK-3532795,BMS955176,BMS-955176,GSK3532795

Cat.No: T25558

Synonym: JNJ 55511118

Cat.No: T11548

Target: Others

Cat.No: T68356

Mcl-1 inhibitor 3

Cat.No: T11972

Target: BCL

Tenofovir-C3-O-C15-CF3 ammonium

Cat.No: T40239

Synonym: Tenofovir-C3-O-C15-CF3 ammonium

HCV-IN-7 hydrochloride

Cat.No: T11548L

Target: Others

Cat.No: T70754

Cat.No: T69761

Cat.No: T69762

BAY-707 acetate

Cat.No: T69776

Resolvin D3 methyl ester

Cat.No: T37290

Cat. No.	Product Name	Target	Signaling Pathways
T8262	Fosfomycin sodium Fosfomycin Disodium,磷霉素钠	Antibacterial; Antibiotic	Microbiology/Virology
	Fosfomycin sodium 是一种能透过血脑屏障的广谱抗生素，不可逆地抑制细胞壁合成的早期阶段。它对多种细菌具有杀菌活性，包括耐多药、广泛耐药和耐全药的细菌。
TN1048	Cnidilin Knidilin
	Cnidilin (Knidilin) 存在与Angelica dahurica 根中，具有高BBB 通透性，在治疗中枢神经系统疾病方面具有药代动力学潜力。
TN4992	Senkyunolide G	Others	Others
	Senkyunolide G and senkyunolide I could serve as pharmacokinetic markers for sepsis care.

天然产物

Fosfomycin sodium

Cat.No: T8262

Synonym: Fosfomycin Disodium,磷霉素钠

Target: Antibacterial, Antibiotic

Cat.No: TN1048

Synonym: Knidilin

Cat.No: TN4992

Target: Others

我们的所有产品和服务仅用于科学研究，不能被用于人体，我们也不向个人提供产品和服务。

Copyright © 2015-2024 TargetMol Chemicals Inc. All rights reserved. 沪ICP备20019793号-4

沪公网安备 31010602006700号

沪公网安备 31010602006700号

TargetMol Loading

联系我们

电话：

400-820-0310

邮箱：

service@tsbiochem.com

QQ：

2881945090（终端用户）

2885109491（经销商）

经销：

终端：

地址：

上海市静安区江场三路238号8楼